Adverse effects: 2. Extrapyramidal ‐ akathisia · patients with schizophrenia
ORAL FLUPHENAZINE probably leads to higher adverse effects: Extrapyramidal effects (akathisia) ‐ short… compared with PLACEBO (moderate certainty).
1 finding from 1 review
Serious adverse effects · participants with olfactory dysfunction following COVID‐19 for ≤ 15 days
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea · people with drug‐resistant focal epilepsy
Rufinamide probably leads to higher adverse effects: nausea compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse effects · HIV‐positive and ‐negative adults and children
MVA85A showed no clear difference in serious adverse effects compared with placebo (high certainty).
1 finding from 1 review
Serious adverse effects · painful diabetic neuropathy
Oxcarbazepine probably leads to higher serious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Adverse event: tremor · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether antidepressants (trazodone 200 mg/day) changes adverse effects: tremor compared with placebo (very low certainty).
1 finding from 1 review
Severe adverse effects ‐ short term Numbers of participants leaving the studies due to severe adverse effects · patients with schizophrenia
It is very uncertain whether TRIFLUOPERAZINE changes severe adverse effects ‐ short term Numbers of participants leaving… compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse effects: 1a. extrapyramidal ‐ various effects ‐ short term (up to 12 weeks) ‐ general ‐ any significant EPS · patients with schizophrenia
RISPERIDONE may leads to higher adverse effects: 1a. extrapyramidal ‐ various effects ‐ short term… compared with PLACEBO (low certainty).
1 finding from 1 review
Adverse effects Range of · participants without prior cerebrovascular disease for prevention of cognitive impairment and dementia
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
Rufinamide probably leads to higher adverse effects: fatigue compared with placebo (moderate certainty).
1 finding from 1 review
Neonatal drug adverse effects · women with perineal pain in the early postpartum period
1 finding from 1 review
Side effects or other adverse events · adolescent and adult menstruating women
Intermittent iron supplementation (alone or with any other… showed no clear difference in any adverse side effects compared with no supplementation or placebo (moderate certainty).
1 finding from 1 review
Clinical adverse effects · children with acute bronchiolitis
1 finding from 1 review
Adverse effects: insomnia · otherwise healthy adults and children with common cold symptoms
Antihistamine‐decongestant showed no clear difference in adverse effects: insomnia compared with placebo (moderate certainty).
1 finding from 1 review
Anxiety (adverse effect, post‐intervention) · post‐caesarean pain
1 finding from 1 review
Anxiety (adverse effect, post‐intervention) · post‐caesarean pain
1 finding from 1 review
Adverse effects: diplopia · people with drug‐resistant focal epilepsy
Rufinamide may leads to higher adverse effects: diplopia compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: headache · people with drug‐resistant focal epilepsy
Rufinamide probably leads to higher adverse effects: headache compared with placebo (moderate certainty).
1 finding from 1 review
Vomiting · people with drug‐resistant focal epilepsy
Rufinamide may leads to higher adverse effects: vomiting compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: insomnia · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether dietary supplements (Catuama herbal compound) changes adverse effects: insomnia compared with placebo (very low certainty).
1 finding from 1 review